🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.140 (-5.30%)
At close: Nov 19, 2026, 4:00 PM EST
2.510
+0.010 (0.40%)
After-hours: Nov 19, 2026, 4:10 PM EST

Intensity Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
5.415.196.093.532.422.16
Research & Development
6.966.7910.54.795.135.86
Operating Expenses
12.3711.9716.598.327.558.01
Operating Income
-12.37-11.97-16.59-8.32-7.55-8.01
Interest Expense
----0.31-0.08-
Interest & Investment Income
0.340.180.310.3200
Other Non Operating Income (Expenses)
-00.1900.020.050.12
EBT Excluding Unusual Items
-12.04-11.61-16.27-8.28-7.58-7.9
Other Unusual Items
----2.26--
Pretax Income
-12.04-11.61-16.27-10.54-7.58-7.9
Net Income
-12.04-11.61-16.27-10.54-7.58-7.9
Preferred Dividends & Other Adjustments
---1.32--
Net Income to Common
-12.04-11.61-16.27-11.86-7.58-7.9
Net Income Growth
------
Shares Outstanding (Basic)
311000
Shares Outstanding (Diluted)
311000
Shares Change
195.11%143.83%61.40%152.67%-0.02%
EPS (Basic)
-4.44-8.56-29.24-34.42-55.58-57.88
EPS (Diluted)
-4.44-8.56-29.24-34.42-55.58-57.88
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBIT
-12.37-11.97-16.59-8.32-7.55-8.01
SEC Filings: 10-K · 10-Q